基于"脑-肠-菌"轴探讨子午流注揿针改善慢传输型便秘大鼠肠道功能的作用机制OA
Mechanism of Meridian-Flow Intradermal Needling in Improving Intestinal Function in Rats with Slow Transit Constipation Based on the"Brain-Gut-Microbiota"Axis
目的 基于"脑-肠-菌"轴理论探讨子午流注揿针对慢传输型便秘(STC)大鼠肠道传输功能的作用机制.方法 选择SPF级Wister大鼠40只,雌雄各半,采用随机数字表法随机分为空白组8只和造模组32只.造模组每日灌胃3 mg/kg盐酸洛哌丁胺混悬液建立STC大鼠模型,连续给药14 d以抑制肠道蠕动;空白组给予等体积生理盐水灌胃.将造模成功后的大鼠随机分为模型组、西药组、普通揿针组和子午流注揿针组,每组8只.除空白组外,其余4组在干预期间继续按造模剂量给予盐酸洛哌丁胺,以维持STC模型稳定,空白组同期灌胃等体积生理盐水.西药组给予琥珀酸普芦卡必利0.18 mg/(kg·d)灌胃,每次1 mL/100 g,每日1次;普通揿针组于每日10:00取双侧天枢穴、大肠俞穴进行揿针干预;子午流注揿针组取穴方法和操作方法与普通揿针组一致,但干预时间是每日辰时(8:00)进行天枢穴干预,申时(16:00)进行大肠俞穴干预.连续干预14 d后,采用6 h内粪便粒数、6 h内粪便含水率、小肠推进率评估大鼠肠道动力;采用ELISA检测结肠组织5-HT、VIP及脑组织中NE蛋白相对表达水平;采用Griess化学法检测脑组织中NO浓度;采用16S rRNA测序分析5组粪便样品的肠道菌群变化;采用京都基因与基因组百科全书(KEGG)分析子午流注揿针组肠道菌群功能基因的富集情况.结果 ① 肠道动力:与空白组比较,模型组6 h内粪便粒数更少(P<0.05),粪便含水率更低(P<0.05),小肠推进率更低(P<0.05);与模型组比较,西药组、普通揿针组及子午流注揿针组大鼠6 h内粪便粒数更多(P<0.05),粪便含水率更高(P<0.05),小肠推进率更高(P<0.05);与普通揿针组比较,西药组和子午流注揿针组6 h内粪便粒数更多(P<0.05),小肠推进率更高(P<0.05).② 脑肠肽水平:与空白组比较,模型组结肠组织5-HT、VIP蛋白相对表达水平更低(P<0.05),脑组织NE蛋白相对表达水平更高(P<0.05),NO浓度更高(P<0.05);与模型组比较,西药组、普通揿针组及子午流注揿针组结肠组织5-HT、VIP蛋白相对表达水平更高(P<0.05),脑组织NE蛋白相对表达水平更低(P<0.05),NO浓度更低(P<0.05);与普通揿针组比较,西药组和子午流注揿针组大鼠结肠组织5-HT、VIP蛋白相对表达水平更高(P<0.05),脑组织NO浓度更低(P<0.05),子午流注揿针组脑组织NE蛋白相对表达水平更低(P<0.05);与西药组比较,子午流注揿针组大鼠结肠组织5-HT、VIP蛋白相对表达水平更高(P<0.05),脑组织NE蛋白相对表达水平更低(P<0.05),NO浓度更低(P<0.05).③ 肠道菌群分析:在OTU水平上,空白组、模型组、西药组、普通揿针组、子午流注揿针组独有OTU数量分别为2 738、3 862、4 397、3 956、2 901,5组共有核心OTU数量有323个.α多样性分析结果显示,与空白组比较,模型组肠道菌群物种丰度及多样性呈下降趋势(P<0.05);与模型组比较,西药组、普通揿针组和子午流注揿针组肠道菌群物种丰度及多样性呈上升趋势(P<0.05),其中子午流注揿针组上升趋势最明显(P<0.05).β多样性分析结果显示,模型组与子午流注揿针组的样本间距离最远.差异物种分析显示,模型组动丝菌属呈较高丰度特征,而子午流注揿针组克雷伯菌属呈相对较高丰度特征,且特异性富集普雷沃氏菌属、拟杆菌属H等菌属;子午流注揿针组肠道菌群功能通路主要集中于代谢相关类别,其中碳水化合物代谢通路相对丰度最高,其次为氨基酸代谢、辅因子和维生素代谢以及萜类和聚酮类化合物代谢通路.结论 子午流注揿针能促进STC大鼠的肠道传输功能恢复,其机制可能与调控"脑-肠-菌"轴以改善肠道动力、恢复脑肠肽动态平衡并优化菌群结构与代谢有关.
Objective To investigate the mechanism of meridian-flow intradermal needling on the intestinal transit function in rats with slow transit constipation(STC)based on the"Brain-Gut-Microbiota"axis theory.Methods Forty SPF-grade Wister rats,with an equal number of male and half female,were randomly assigned into a blank group(8 rats)and a modeling group(32 rats)using the random number table method.Rats in the modeling group were intragastrically administered 3 mg/kg loperamide hydro-chloride suspension daily for 14 consecutive days to establish the STC rat model by inhibiting intestinal peristalsis.Meanwhile,the blank group received an equal volume of normal saline by gavage.Rats with successful model establisment were randomly divided into a model group,a western medicine group,the common intradermal needle group,and the meridian-flow intradermal needling group,with eight rats in each group.During the intervention period,all groups except the blank group continued to receive loper-amide hydrochloride at the modeling dose to maintain a stable STC model,and the blank group was given an equal volume of normal saline simultaneously.The western medicine group was intragastrically administered prucalopride succinate at a dosage of 0.18 mg/(kg·d),with a volume of 1 mL per 100 g body weight,once daily.The common intradermal needle group received intrader-mal needling at bilateral Tianshu(ST25)and Dachangshu(BL25)acupoints at 10:00 AM every day.The meridian-flow intradermal needling group used the identical acupoints and procedures as the common intradermal needle group,but with time-specific interven-tion:Tianshu was needled at the Chen hour(08:00 AM)and Dachangshu at the Shen hour(16:00 PM)daily.Following 14 consecu-tive days of intervention,intestinal motility was evaluated by the number of fecal particles within 6 hours,fecal water content,and the small intestinal propulsion rate.The relative protein expression levels of 5-hydroxytryptamine(5-HT)and vasoactive intestinal peptide(VIP)in colon tissue and norepinephrine(NE)in brain tissue were detected by enzyme-linked immunosorbent assay(ELI-SA).Nitric oxide(NO)concentration in brain tissue was measured by the Griess chemical method.Intestinal microbiota alterations in fecal samples from the five groups were analyzed by 16S rRNA gene sequencing.The functional gene enrichment of intestinal microbiota in the meridian-flow intradermal needling group was analyzed using the Kyoto Encyclopedia of Genes and Genomes(KEGG)database.Results 1)Intestinal motility:Compared with the blank group,the model group showed fewer fecal particles within 6 hours(P<0.05),a lower fecal water content(P<0.05),and a lower small-intestinal propulsion rate(P<0.05).Compared with the model group,the western medicine group,the common intradermal needle group,and the meridian-flow intradermal needling group exhibited a greater number of fecal particles within 6 hours(P<0.05),a higher fecal water content(P<0.05),and a higher small intestinal propulsion rate(P<0.05).Compared with the common intradermal needle group,the western medicine group and the meridian-flow intradermal needling group exhibited a greater number of fecal particles within 6 hours(P<0.05),and a higher small intestinal propulsion rate(P<0.05).2)Brain-gut peptide levels:Compared with the blank group,the model group presented a lower protein expression levels of 5-HT and VIP in colon tissue(P<0.05),a higher protein expression of NE in brain tissue(P<0.05),and a higher NO concentration(P<0.05).Compared with the model group,the western medicine group,the common intradermal needle group,and the meridian-flow intradermal needling group showed a higher protein expressions of 5-HT and VIP in colon tissues(P<0.05),a lower protein expression of NE in brain tissues(P<0.05),and a lower NO concentration(P<0.05).Compared with the com-mon intradermal needle group,the western medicine group and the meridian-flow intradermal needling group had a higher protein expressions of 5-HT and VIP in colon tissue(P<0.05)and a lower NO concentration in brain tissue(P<0.05);the meridian-flow intradermal needling group also demonstrated a lower protein expression of NE in brain tissue(P<0.05).Compared with the western medicine group,the meridian-flow intradermal needling group displayed a higher protein expressions of 5-HT and VIP in colon tis-sue(P<0.05),a lower protein expression of NE in brain tissue(P<0.05),and a lower NO concentration(P<0.05).3)Intestinal micro-biota analysis:At the OTU level,the numbers of unique OTUs in the blank,model,western medicine,the common intradermal nee-dle,and the meridian-flow intradermal needling groups were 2,738,3,862,4,397,3,956,and 2,901,respectively,with 323 core OTUs shared by all five groups.α-diversity analysis revealed that compared with the blank group,the model group showed a de-creasing trend in species abundance and diversity of gut microbiota(P<0.05).Compared with the model group,the western medicine group,the common intradermal needle group,and the meridian-flow intradermal needling group exhibited an increasing trend in the abundance and diversity of intestinal microbiota(P<0.05),with the most significant increase in the meridian-flow intradermal nee-dling group(P<0.05).The β-diversity analysis demonstrated the greatest inter-sample distance between the model group and the me-ridian-flow intradermal needling group.Differential species analysis indicated that the model group was characterized by high abun-dance of Kineothrix,whereas the meridian-flow intradermal needling group exhibited a relatively high abundance of Klebsiella and specific enrichment of Prevotella,Bacteroides H,and other genera.The functional pathways of the intestinal microbiota in the merid-ian-flow intradermal needling group were mainly concentrated in metabolism-related pathways.Among these,the carbohydrate me-tabolism had the highest relative abundance,followed by amino acid metabolism,the metabolism of cofactors and vitamins,and the metabolism of terpenoids and polyketides.Conclusion The meridian-flow intradermal needling can promote the recovery of intes-tinal transit function in STC rats.Its mechanism may be related to the regulation of the"Brain-Gut-Microbiota"axis,thereby improv-ing intestinal motility,restoring the homeostasis of brain-gut peptides,and optimizing the structure and metabolism of the microbiota.
陈慧;许清媛;李旭雯;丘杭燕;沈瑜欣;李春平;王志福
福建中医药大学附属第二人民医院,福建 福州 350003福建中医药大学护理学院,福建 福州 350122福建中医药大学护理学院,福建 福州 350122福建中医药大学护理学院,福建 福州 350122福建中医药大学护理学院,福建 福州 350122福建中医药大学附属第二人民医院,福建 福州 350003福建中医药大学针灸推拿学院,福建 福州 350122
慢传输型便秘脑-肠-菌轴子午流注揿针肠道菌群脑肠肽
slow transit constipation"Brain-Gut-Microbiota"axisthe meridian-flow intradermal needlingintestinal microbiotabrain-gut peptides
《康复学报》 2026 (4)
285-298,14
国家自然科学基金面上项目(82575226)福建省自然科学基金项目(2023J01822)
评论